Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin P Howden

Showing results (1-10 of 376) with videos related to

Pageof 38
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|December 17, 2013
Antibiotics and Staphylococcus aureus--more than meets the MICBenjamin P Howden
Current Opinion in Infectious Diseases|September 10, 2009
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibioticsKyra Chua, Benjamin P Howden
The Lancet. Microbe|May 11, 2026
A global economic perspective on whole-genome sequencing strategies for pathogens: continuous surveillance versus outbreak-triggered investigationsAdrian Egli, Benjamin P Howden
Expert Review of Anti-Infective Therapy|June 23, 2011
The rise of antimicrobial resistance: a clear and present dangerNatasha E Holmes, Benjamin P Howden
The Medical Journal of Australia|June 12, 2002
5: Hospital-in-the-home treatment of infectious diseasesBenjamin P Howden, M Lindsay Grayson
Expert Review of Anti-Infective Therapy|May 8, 2015
Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practiceJean Yh Lee, Benjamin P Howden
Current Opinion in Infectious Diseases|September 12, 2014
What's new in the treatment of serious MRSA infection?Natasha E Holmes, Benjamin P Howden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureusBenjamin P Howden, M Lindsay Grayson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2017
The Critical Importance of Sampling Fraction to Inferences of Mycobacterium tuberculosis TransmissionRobyn S Lee, Benjamin P Howden
Expert Opinion on Emerging Drugs|March 16, 2007
Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directionsEmma J Bishop, Benjamin P Howden
Pageof 38

Showing results (1-10 of 376) with videos related to

Sort By:
Pageof 38
Journal of Molecular Medicine (Berlin, Germany)|December 17, 2013
Antibiotics and Staphylococcus aureus--more than meets the MICBenjamin P Howden
Current Opinion in Infectious Diseases|September 10, 2009
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibioticsKyra Chua, Benjamin P Howden
The Lancet. Microbe|May 11, 2026
A global economic perspective on whole-genome sequencing strategies for pathogens: continuous surveillance versus outbreak-triggered investigationsAdrian Egli, Benjamin P Howden
Expert Review of Anti-Infective Therapy|June 23, 2011
The rise of antimicrobial resistance: a clear and present dangerNatasha E Holmes, Benjamin P Howden
The Medical Journal of Australia|June 12, 2002
5: Hospital-in-the-home treatment of infectious diseasesBenjamin P Howden, M Lindsay Grayson
Expert Review of Anti-Infective Therapy|May 8, 2015
Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practiceJean Yh Lee, Benjamin P Howden
Current Opinion in Infectious Diseases|September 12, 2014
What's new in the treatment of serious MRSA infection?Natasha E Holmes, Benjamin P Howden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureusBenjamin P Howden, M Lindsay Grayson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2017
The Critical Importance of Sampling Fraction to Inferences of Mycobacterium tuberculosis TransmissionRobyn S Lee, Benjamin P Howden
Expert Opinion on Emerging Drugs|March 16, 2007
Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directionsEmma J Bishop, Benjamin P Howden
Pageof 38